Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.
The peroxisome proliferator-activated receptors (PPAR) are ligand-activated transcription factors that belong to the nuclear hormone receptor family. Three isotypes (PPAR alpha, PPAR beta or delta, and PPAR gamma) with distinct tissue distributions and cellular functions have been found in vertebrates. All three PPAR isotypes are expressed in rodent and human skin. They were initially investigated for a possible function in the establishment of the permeability barrier in skin because of their known function in lipid metabolism in other cell types. In vitro studies using specific PPAR agonists and in vivo gene disruption approaches in mice indeed suggest an important contribution of PPAR alpha in the formation of the epidermal barrier and in sebocyte differentiation. The PPAR gamma isotype plays a role in stimulating sebocyte development and lipogenesis, but does not appear to contribute to epidermal tissue differentiation. The third isotype, PPAR beta, regulates the late stages of sebaceous cell differentiation, and is the most effective isotype in stimulating lipid production in these cells, both in rodents and in humans. In addition, PPAR beta activation has pro-differentiating effects in keratinocytes under normal and inflammatory conditions. Finally, preliminary studies also point to a potential role of PPAR in hair follicle growth and in melanocyte differentiation. By their diverse biological effects on cell proliferation and differentiation in the skin, PPAR agonists or antagonists may offer interesting opportunities for the treatment of various skin disorders characterized by inflammation, cell hyperproliferation, and aberrant differentiation.
Di-Poï
Nicolas
N
Center for Integrative Genomics, NCCR Frontiers in Genetics, University of Lausanne, CH-1015 Lausanne, Switzerland.
Michalik
Liliane
L
Desvergne
Béatrice
B
Wahli
Walter
W
D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D006706:Homeostasis; D006801:Humans; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism*; D012867:Skin / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D012871:Skin Diseases / Q000378:metabolism / Q000473:pathology
D047492:Peroxisome Proliferator-Activated Receptors
Endocr Rev. 1999 Oct;20(5):649-88
10529898
Development. 2001 Mar;128(5):675-88
11171393
J Cell Biol. 2001 Aug 20;154(4):799-814
11514592
Acta Derm Venereol. 2000 Sep-Oct;80(5):329-34
11200828
J Biol Chem. 2000 Apr 14;275(15):11484-91
10753967
Genes Dev. 2001 Dec 15;15(24):3263-77
11751632
Mol Cell Biol. 1995 Jun;15(6):3012-22
7539101
J Invest Dermatol. 2004 Apr;122(4):971-83
15102088
Mol Cell. 1999 Oct;4(4):611-7
10549292
Mol Cell. 1999 Oct;4(4):585-95
10549290
J Invest Dermatol. 1998 Dec;111(6):1116-21
9856826
J Investig Dermatol Symp Proc. 1998 Aug;3(2):75-9
9734818
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):257-65
12943711
Curr Opin Lipidol. 2003 Apr;14(2):129-35
12642780
J Invest Dermatol. 2000 Sep;115(3):361-7
10951269
Nature. 2000 May 25;405(6785):421-4
10839530
J Invest Dermatol. 2000 Feb;114(2):349-53
10651997
Prog Lipid Res. 2001 Jul;40(4):269-81
11412892
J Dermatol. 1998 Sep;25(9):587-96
9798345
J Invest Dermatol. 1999 Oct;113(4):523-32
10504436
Mol Genet Metab. 2001 Nov;74(3):362-9
11708867
J Biol Chem. 1995 Oct 13;270(41):23975-83
7592593
Dermatology. 1998;196(1):43-6
9557223
Mol Endocrinol. 1997 Jun;11(6):779-91
9171241
Mol Cell Biol. 2000 Jul;20(14):5119-28
10866668
J Invest Dermatol. 1999 Feb;112(2):226-32
9989800
Int J Dev Biol. 2002 Jan;46(1):105-14
11902671
Mol Cell Endocrinol. 1999 Jan 25;147(1-2):85-92
10195695
J Invest Dermatol. 1998 Apr;110(4):368-75
9540977
J Invest Dermatol. 1998 Sep;111(3):429-33
9740236
J Clin Invest. 1997 Aug 1;100(3):705-12
9239419
Dermatology. 2003;206(3):252-6
12673084
J Invest Dermatol. 2002 Sep;119(3):576-82
12230498
Endocrinology. 1998 Jun;139(6):2748-54
9607781
Br J Dermatol. 2004 Mar;150(3):462-8
15030328
Endocrinology. 1996 Jan;137(1):354-66
8536636
J Invest Dermatol. 2000 Apr;114(4):681-7
10733673
J Invest Dermatol. 2003 Sep;121(3):441-7
12925198
J Invest Dermatol. 2001 May;116(5):702-12
11348458
Arch Dermatol. 2000 May;136(5):609-16
10815854
J Invest Dermatol. 2002 Dec;119(6):1298-303
12485431
J Invest Dermatol. 2000 Sep;115(3):353-60
10951268
Mol Cell. 2002 Oct;10(4):721-33
12419217
J Invest Dermatol. 1999 Nov;113(5):788-95
10571735
J Invest Dermatol. 2003 Nov;121(5):1104-17
14708613
Horm Res. 2003;60(1):1-13
12792148